PKCζ-IN-1 is a compound that inhibits PKCζ and CDK2, exhibiting an IC50 value of 5.18 nM against PKCζ and 1.04 μM against CDK2, with a selectivity ratio of approximately 200-fold for PKCζ over CDK2. It is used to suppress the activity of PKCζ and concurrently reduce CDK2 activity.